SCHEMBL506280

SCHEMBL506280

CCOC(O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL866329 0.83
SCHEMBL4146828 0.80
SCHEMBL18687786 0.75
SCHEMBL1157679 0.75
SCHEMBL8991000 0.73
SCHEMBL1184727 0.73 LMNA (0.45)
SCHEMBL6818449 0.73
SCHEMBL8541517 0.73
SCHEMBL8866099 0.73
SCHEMBL588236 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102388014-A Synthesis method of chiral alpha-aryl propionic acid derivative DSM IP ASSETS BV 2012-03-21 CN claimed
US-20120029226-A1 METHOD FOR THE SYNTHESIS OF CHIRAL ALPHA-ARYL PROPIONIC ACID DERIVATIVES DSM IP ASSETS B.V. (NL) 2012-02-02 US claimed
EP-2393771-A1 Method for the synthesis of chiral alpha-aryl propionic acid derivatives DSM IP Assets B.V. (NL) 2011-12-14 EP claimed
WO-2010089343-A1 METHOD FOR THE SYNTHESIS OF CHIRAL ALPHA-ARYL PROPIONIC ACID DERIVATIVES DSM IP ASSETS B.V. (NL) 2010-08-12 WO claimed
US-20090131437-A1 DISUBSTITUTED UREAS AS KINASE INHIBITORS CORIUM INTERNATIONAL, INC. (US) 2009-05-21 US claimed
EP-1838700-A2 DISUBSTITUTED UREAS AS KINASE INHIBITORS Novartis AG (CH) 2007-10-03 EP claimed
CN-1950335-A Novel biaromatic compounds which activate PPAR.gamma.-type receptors, their process of preparation and their use in cosmetic or pharmaceutical compositions GALDERMA RES & DEV (FR) 2007-04-18 CN claimed
WO-2006072589-A2 DISUBSTITUTED UREAS AS KINASE INHIBITORS NOVARTIS AG (CH) 2006-07-13 WO claimed
CN-1184200-C Bi-aromatic compounds bond by a heteroethynytene radical and pharmaceutical and comsmetic compositions containing same GALDERMA RES & DEV I (FR) 2005-01-12 CN claimed
CN-1236359-A Bi-aromatic compounds bond by a heteroethynytene radical and pharmaceutical and comsmetic compositions containing same GALDERMA RES & DEV (FR) 1999-11-24 CN claimed
EP-0519731-B1 4a-Substituted avermectin derivatives MERCK & CO INC (US) 1998-01-28 EP claimed
EP-0537998-B1 Controlled release drug delivery device comprising a polymer matrix and a plasticizer MERCK & CO INC (US) 1997-01-15 EP claimed
US-5411737-A Flea and tick collars MERCK & CO., INC. (US) 1995-05-02 US claimed
US-5262400-A Antiparasitic and anthelmintic MERCK & CO., INC. (US) 1993-11-16 US claimed
EP-0519731-A1 4a-Substituted avermectin derivatives MERCK & CO. INC. (US) 1992-12-23 EP claimed
CN-118702552-A Preparation method of methoxyethoxy chloromethane 浙江国邦药业有限公司 2024-09-27 CN disclosed
US-20230322742-A1 ORTHOESTER COMPOSITIONS FOR AFFINITY PURIFICATION OF OLIGONUCLEOTIDES AGILENT TECHNOLOGIES, INC. 2023-10-12 US disclosed
EP-0519731-A1 4a-Substituted avermectin derivatives MERCK & CO. INC. (US) 1992-12-23 EP disclosed
EP-0356234-A2 New Benzazole compounds, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-02-28 EP disclosed
US-4217274-A Methoxyethoxymethyl esters of penicillins BRISTOL-MYERS COMPANY (US) 1980-08-12 US disclosed